Stock News

Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
11 Oversold Biotech Stocks To Buy Right Now
Gilead CAR-T cancer therapy capacity to quadruple by 2026
12 Most Profitable Biotech Stocks To Invest In
Gilead Sciences Inc's Dividend Analysis
15 Best NASDAQ Dividend Stocks To Buy
Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities
Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers

As seen on...